Instructions and precautions for use of 0.01% Atropine Sulfate Eye Drops-EIKANCE

0.01% Atropine Sulfate Eye Drops (EIKANCE) is a drug used to control the progression of myopia in children and is often recommended as part of myopia prevention and control. It slows down the progression of myopia by reducing the adjustment ability of the eyeball and reducing intraocular pressure when using the eyes at close range. This drug is particularly suitable for children and adolescents aged 6 and above, especially those whose myopia increases rapidly.

Drug composition and principle of action

0.01%The main ingredient of Atropine Sulfate Eye Drops is atropine sulfate, which is an anticholinergic drug. It reduces the stress on the eyes when focusing at close range by inhibiting the accommodation of the eye's ciliary muscles. Clinical studies have shown that low-concentration atropine can significantly slow down the progression of myopia without causing obvious side effects, making it a first-line drug in the treatment of myopia control in children.

How to use

This medication is usually administered through eye drops, and the dosage of eye drops needs to be administered according to the specific instructions of your doctor. Typically, one drop of medication is applied to each eye daily. Patients should follow medical instructions to ensure correct use of medications. For pediatric patients, parents or guardians need to assist in the use and monitoring of the medication process to ensure that the medication is not misused or dripped into other areas other than the eyes.

Precautions for use

When using0.01%Atropine Sulfate Eye Drops, first make sure the eyes are clean. You can gently wash the area around the eyes with warm water before use. After using the drug, patients may experience minor eye discomfort, such as dryness of the eyes or temporary blurred vision. These are usually temporary side effects of the drug. If symptoms persist or worsen, you should consult your doctor promptly.

Additionally, patients should not wear contact lenses during use, especially early in treatment. Patients with a history of allergies or allergies to atropine drugs should avoid using this drug and consult their doctor about other alternatives. During use, go to the hospital regularly to review your vision and eye health to ensure the effectiveness of the treatment.

Contraindications and Risks

0.01%Contraindications to atropine sulfate eye drops include patients who are allergic to atropine sulfate or other components of the drug. In addition, patients with diseases such as elevated intraocular pressure, glaucoma, and eye infections are not suitable to use this drug. During treatment, if redness of the eyes, significant blurred vision, or other serious discomfort occurs, the drug should be discontinued immediately and seek medical attention.

In general, 0.01%Atropine sulfate eye drops are currently one of the effective drugs to control the progression of myopia, but patients need to use it under the guidance of a doctor to ensure safety and efficacy.

Reference materials:https://www.medsafe.govt.nz/profs/datasheet/e/EikanceEyeDrops.pdf